The global market for Human Thrombin for Extemal Use (Freeze-dried) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Human Thrombin for Extemal Use (Freeze-dried) is a topical thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.

North American market for Human Thrombin for Extemal Use (Freeze-dried) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Thrombin for Extemal Use (Freeze-dried) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Human Thrombin for Extemal Use (Freeze-dried) include Baxter, CSL, VeraSeal, Octapharma, Kedrion, Pfizer, Johnson & Johnson, Cellphire, Inc., Hualanbio, Zelgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Thrombin for Extemal Use (Freeze-dried), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Thrombin for Extemal Use (Freeze-dried).

The Human Thrombin for Extemal Use (Freeze-dried) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Thrombin for Extemal Use (Freeze-dried) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Thrombin for Extemal Use (Freeze-dried) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Thrombin for Extemal Use (Freeze-dried) Market Report

Report Metric	Details
Report Name	Human Thrombin for Extemal Use (Freeze-dried) Market
Segment by Type	500IU 1000IU 2500IU
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, CSL, VeraSeal, Octapharma, Kedrion, Pfizer, Johnson & Johnson, Cellphire, Inc., Hualanbio, Zelgen, Raas-corp
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Thrombin for Extemal Use (Freeze-dried) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Thrombin for Extemal Use (Freeze-dried) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Thrombin for Extemal Use (Freeze-dried) Market report?

Ans: The main players in the Human Thrombin for Extemal Use (Freeze-dried) Market are Baxter, CSL, VeraSeal, Octapharma, Kedrion, Pfizer, Johnson & Johnson, Cellphire, Inc., Hualanbio, Zelgen, Raas-corp

What are the Application segmentation covered in the Human Thrombin for Extemal Use (Freeze-dried) Market report?

Ans: The Applications covered in the Human Thrombin for Extemal Use (Freeze-dried) Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Human Thrombin for Extemal Use (Freeze-dried) Market report?

Ans: The Types covered in the Human Thrombin for Extemal Use (Freeze-dried) Market report are 500IU, 1000IU, 2500IU

1 Human Thrombin for Extemal Use (Freeze-dried) Market Overview

1.1 Product Definition

1.2 Human Thrombin for Extemal Use (Freeze-dried) by Type

1.2.1 Global Human Thrombin for Extemal Use (Freeze-dried) Market Value Comparison by Type (2024 VS 2031)

1.2.2 500IU

1.2.3 1000IU

1.2.4 2500IU

1.3 Human Thrombin for Extemal Use (Freeze-dried) by Application

1.3.1 Global Human Thrombin for Extemal Use (Freeze-dried) Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Human Thrombin for Extemal Use (Freeze-dried) Market Size Estimates and Forecasts

1.4.1 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue 2020-2031

1.4.2 Global Human Thrombin for Extemal Use (Freeze-dried) Sales 2020-2031

1.4.3 Global Human Thrombin for Extemal Use (Freeze-dried) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Thrombin for Extemal Use (Freeze-dried) Market Competition by Manufacturers

2.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Thrombin for Extemal Use (Freeze-dried) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Thrombin for Extemal Use (Freeze-dried), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Thrombin for Extemal Use (Freeze-dried), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Thrombin for Extemal Use (Freeze-dried), Product Type & Application

2.7 Global Key Manufacturers of Human Thrombin for Extemal Use (Freeze-dried), Date of Enter into This Industry

2.8 Global Human Thrombin for Extemal Use (Freeze-dried) Market Competitive Situation and Trends

2.8.1 Global Human Thrombin for Extemal Use (Freeze-dried) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Thrombin for Extemal Use (Freeze-dried) Players Market Share by Revenue

2.8.3 Global Human Thrombin for Extemal Use (Freeze-dried) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Thrombin for Extemal Use (Freeze-dried) Market Scenario by Region

3.1 Global Human Thrombin for Extemal Use (Freeze-dried) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Region: 2020-2031

3.2.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Region: 2020-2025

3.2.2 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Region: 2026-2031

3.3 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region: 2020-2031

3.3.1 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region: 2020-2025

3.3.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region: 2026-2031

3.4 North America Human Thrombin for Extemal Use (Freeze-dried) Market Facts & Figures by Country

3.4.1 North America Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2031)

3.4.3 North America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Human Thrombin for Extemal Use (Freeze-dried) Market Facts & Figures by Country

3.5.1 Europe Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2031)

3.5.3 Europe Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Market Facts & Figures by Region

3.6.1 Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Human Thrombin for Extemal Use (Freeze-dried) Market Facts & Figures by Country

3.7.1 Latin America Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2031)

3.7.3 Latin America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Type (2020-2031)

4.1.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Type (2020-2025)

4.1.2 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Type (2026-2031)

4.1.3 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Type (2020-2031)

4.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Type (2020-2031)

4.2.1 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Type (2020-2025)

4.2.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Type (2026-2031)

4.2.3 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Type (2020-2031)

4.3 Global Human Thrombin for Extemal Use (Freeze-dried) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Application (2020-2031)

5.1.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Application (2020-2025)

5.1.2 Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Application (2026-2031)

5.1.3 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Application (2020-2031)

5.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Application (2020-2031)

5.2.1 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Application (2020-2025)

5.2.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Application (2026-2031)

5.2.3 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Application (2020-2031)

5.3 Global Human Thrombin for Extemal Use (Freeze-dried) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Company Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Baxter Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 VeraSeal

6.3.1 VeraSeal Company Information

6.3.2 VeraSeal Description and Business Overview

6.3.3 VeraSeal Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 VeraSeal Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.3.5 VeraSeal Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Kedrion

6.5.1 Kedrion Company Information

6.5.2 Kedrion Description and Business Overview

6.5.3 Kedrion Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Kedrion Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.5.5 Kedrion Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Company Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pfizer Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Johnson & Johnson

6.7.1 Johnson & Johnson Company Information

6.7.2 Johnson & Johnson Description and Business Overview

6.7.3 Johnson & Johnson Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Johnson & Johnson Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.7.5 Johnson & Johnson Recent Developments/Updates

6.8 Cellphire, Inc.

6.8.1 Cellphire, Inc. Company Information

6.8.2 Cellphire, Inc. Description and Business Overview

6.8.3 Cellphire, Inc. Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Cellphire, Inc. Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.8.5 Cellphire, Inc. Recent Developments/Updates

6.9 Hualanbio

6.9.1 Hualanbio Company Information

6.9.2 Hualanbio Description and Business Overview

6.9.3 Hualanbio Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Hualanbio Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.9.5 Hualanbio Recent Developments/Updates

6.10 Zelgen

6.10.1 Zelgen Company Information

6.10.2 Zelgen Description and Business Overview

6.10.3 Zelgen Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Zelgen Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.10.5 Zelgen Recent Developments/Updates

6.11 Raas-corp

6.11.1 Raas-corp Company Information

6.11.2 Raas-corp Description and Business Overview

6.11.3 Raas-corp Human Thrombin for Extemal Use (Freeze-dried) Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Raas-corp Human Thrombin for Extemal Use (Freeze-dried) Product Portfolio

6.11.5 Raas-corp Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Thrombin for Extemal Use (Freeze-dried) Industry Chain Analysis

7.2 Human Thrombin for Extemal Use (Freeze-dried) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Thrombin for Extemal Use (Freeze-dried) Production Mode & Process Analysis

7.4 Human Thrombin for Extemal Use (Freeze-dried) Sales and Marketing

7.4.1 Human Thrombin for Extemal Use (Freeze-dried) Sales Channels

7.4.2 Human Thrombin for Extemal Use (Freeze-dried) Distributors

7.5 Human Thrombin for Extemal Use (Freeze-dried) Customer Analysis

8 Human Thrombin for Extemal Use (Freeze-dried) Market Dynamics

8.1 Human Thrombin for Extemal Use (Freeze-dried) Industry Trends

8.2 Human Thrombin for Extemal Use (Freeze-dried) Market Drivers

8.3 Human Thrombin for Extemal Use (Freeze-dried) Market Challenges

8.4 Human Thrombin for Extemal Use (Freeze-dried) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Human Thrombin for Extemal Use (Freeze-dried) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Thrombin for Extemal Use (Freeze-dried) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Thrombin for Extemal Use (Freeze-dried) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Thrombin for Extemal Use (Freeze-dried) Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Thrombin for Extemal Use (Freeze-dried), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Thrombin for Extemal Use (Freeze-dried), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Thrombin for Extemal Use (Freeze-dried), Product Type & Application

Table 12. Global Key Manufacturers of Human Thrombin for Extemal Use (Freeze-dried), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Thrombin for Extemal Use (Freeze-dried) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Thrombin for Extemal Use (Freeze-dried) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Thrombin for Extemal Use (Freeze-dried) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Region (2020-2025) & (K Units)

Table 18. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Region (2020-2025)

Table 19. Global Human Thrombin for Extemal Use (Freeze-dried) Sales by Region (2026-2031) & (K Units)

Table 20. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Region (2026-2031)

Table 21. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Region (2020-2025)

Table 23. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Region (2026-2031)

Table 25. North America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2025) & (K Units)

Table 27. North America Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2026-2031) & (K Units)

Table 28. North America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units) by Type (2020-2025)

Table 51. Global Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units) by Type (2026-2031)

Table 52. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Type (2020-2025)

Table 53. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Type (2026-2031)

Table 54. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Type (2020-2025)

Table 57. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Type (2026-2031)

Table 58. Global Human Thrombin for Extemal Use (Freeze-dried) Price (US$/Unit) by Type (2020-2025)

Table 59. Global Human Thrombin for Extemal Use (Freeze-dried) Price (US$/Unit) by Type (2026-2031)

Table 60. Global Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units) by Application (2020-2025)

Table 61. Global Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units) by Application (2026-2031)

Table 62. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Application (2020-2025)

Table 63. Global Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Application (2026-2031)

Table 64. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Application (2020-2025)

Table 67. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Application (2026-2031)

Table 68. Global Human Thrombin for Extemal Use (Freeze-dried) Price (US$/Unit) by Application (2020-2025)

Table 69. Global Human Thrombin for Extemal Use (Freeze-dried) Price (US$/Unit) by Application (2026-2031)

Table 70. Baxter Company Information

Table 71. Baxter Description and Business Overview

Table 72. Baxter Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Baxter Human Thrombin for Extemal Use (Freeze-dried) Product

Table 74. Baxter Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. CSL Human Thrombin for Extemal Use (Freeze-dried) Product

Table 79. CSL Recent Developments/Updates

Table 80. VeraSeal Company Information

Table 81. VeraSeal Description and Business Overview

Table 82. VeraSeal Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. VeraSeal Human Thrombin for Extemal Use (Freeze-dried) Product

Table 84. VeraSeal Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Octapharma Human Thrombin for Extemal Use (Freeze-dried) Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Kedrion Company Information

Table 91. Kedrion Description and Business Overview

Table 92. Kedrion Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Kedrion Human Thrombin for Extemal Use (Freeze-dried) Product

Table 94. Kedrion Recent Developments/Updates

Table 95. Pfizer Company Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Pfizer Human Thrombin for Extemal Use (Freeze-dried) Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Johnson & Johnson Company Information

Table 101. Johnson & Johnson Description and Business Overview

Table 102. Johnson & Johnson Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Johnson & Johnson Human Thrombin for Extemal Use (Freeze-dried) Product

Table 104. Johnson & Johnson Recent Developments/Updates

Table 105. Cellphire, Inc. Company Information

Table 106. Cellphire, Inc. Description and Business Overview

Table 107. Cellphire, Inc. Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Cellphire, Inc. Human Thrombin for Extemal Use (Freeze-dried) Product

Table 109. Cellphire, Inc. Recent Developments/Updates

Table 110. Hualanbio Company Information

Table 111. Hualanbio Description and Business Overview

Table 112. Hualanbio Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Hualanbio Human Thrombin for Extemal Use (Freeze-dried) Product

Table 114. Hualanbio Recent Developments/Updates

Table 115. Zelgen Company Information

Table 116. Zelgen Description and Business Overview

Table 117. Zelgen Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Zelgen Human Thrombin for Extemal Use (Freeze-dried) Product

Table 119. Zelgen Recent Developments/Updates

Table 120. Raas-corp Company Information

Table 121. Raas-corp Description and Business Overview

Table 122. Raas-corp Human Thrombin for Extemal Use (Freeze-dried) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Raas-corp Human Thrombin for Extemal Use (Freeze-dried) Product

Table 124. Raas-corp Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Human Thrombin for Extemal Use (Freeze-dried) Distributors List

Table 128. Human Thrombin for Extemal Use (Freeze-dried) Customers List

Table 129. Human Thrombin for Extemal Use (Freeze-dried) Market Trends

Table 130. Human Thrombin for Extemal Use (Freeze-dried) Market Drivers

Table 131. Human Thrombin for Extemal Use (Freeze-dried) Market Challenges

Table 132. Human Thrombin for Extemal Use (Freeze-dried) Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Thrombin for Extemal Use (Freeze-dried)

Figure 2. Global Human Thrombin for Extemal Use (Freeze-dried) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Thrombin for Extemal Use (Freeze-dried) Market Share by Type: 2024 & 2031

Figure 4. 500IU Product Picture

Figure 5. 1000IU Product Picture

Figure 6. 2500IU Product Picture

Figure 7. Global Human Thrombin for Extemal Use (Freeze-dried) Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Human Thrombin for Extemal Use (Freeze-dried) Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Human Thrombin for Extemal Use (Freeze-dried) Market Size (2020-2031) & (US$ Million)

Figure 14. Global Human Thrombin for Extemal Use (Freeze-dried) Sales (2020-2031) & (K Units)

Figure 15. Global Human Thrombin for Extemal Use (Freeze-dried) Average Price (US$/Unit) & (2020-2031)

Figure 16. Human Thrombin for Extemal Use (Freeze-dried) Report Years Considered

Figure 17. Human Thrombin for Extemal Use (Freeze-dried) Sales Share by Manufacturers in 2024

Figure 18. Global Human Thrombin for Extemal Use (Freeze-dried) Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Human Thrombin for Extemal Use (Freeze-dried) Players: Market Share by Revenue in Human Thrombin for Extemal Use (Freeze-dried) in 2024

Figure 20. Human Thrombin for Extemal Use (Freeze-dried) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Human Thrombin for Extemal Use (Freeze-dried) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Country (2020-2031)

Figure 23. North America Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Country (2020-2031)

Figure 24. United States Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Country (2020-2031)

Figure 27. Europe Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Country (2020-2031)

Figure 28. Germany Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Region (2020-2031)

Figure 35. China Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Country (2020-2031)

Figure 43. Latin America Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Human Thrombin for Extemal Use (Freeze-dried) Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Human Thrombin for Extemal Use (Freeze-dried) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Human Thrombin for Extemal Use (Freeze-dried) by Type (2020-2031)

Figure 53. Global Revenue Market Share of Human Thrombin for Extemal Use (Freeze-dried) by Type (2020-2031)

Figure 54. Global Human Thrombin for Extemal Use (Freeze-dried) Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Human Thrombin for Extemal Use (Freeze-dried) by Application (2020-2031)

Figure 56. Global Revenue Market Share of Human Thrombin for Extemal Use (Freeze-dried) by Application (2020-2031)

Figure 57. Global Human Thrombin for Extemal Use (Freeze-dried) Price (US$/Unit) by Application (2020-2031)

Figure 58. Human Thrombin for Extemal Use (Freeze-dried) Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions